Literature DB >> 16049281

Expression of apoptosis related proteins during malignant progression in chronic ulcerative colitis.

C J van der Woude1, H Moshage, M Homan, J H Kleibeuker, P L M Jansen, H van Dekken.   

Abstract

BACKGROUND: Chronic ulcerative colitis (CUC) is associated with increased risk of developing colon cancer through a dysplasia (intraepithelial neoplasia)-carcinoma sequence. AIMS: To investigate the expression of apoptosis and inflammatory related proteins in CUC.
METHODS: The expression of proteins involved in apoptosis and inflammation (inducible nitric oxide synthase (iNOS), cyclooxygenase 2 (COX-2), Bcl-xl, Fas, and active caspase 3) was investigated and compared with that seen in sporadic colon carcinoma.
RESULTS: COX-2 was negative in the epithelium of all samples. iNOS was clearly present in inflammatory areas in CUC epithelium, weakly expressed in dysplasia, and absent or weakly expressed in tumour cells. Bcl-xl was absent in CUC, increased in dysplasia, and highly expressed in most carcinomas. Fas expression was positive in the surface epithelium of CUC, dysplasia, and most tumour cells. Activated caspase 3 was weakly positive in all samples, indicating limited apoptosis. Compared with CUC associated carcinoma, iNOS was consistently expressed in sporadic colon carcinoma cells, whereas Bcl-xl was almost absent in these tumour cells and Fas was only weakly expressed. Activated caspase 3 was present in normal mucosal samples and some tumour cells.
CONCLUSION: Apoptosis related proteins--particularly iNOS, Bcl-xl, and Fas-show a distinct pattern of expression in the CUC to carcinoma sequence, which differs from that seen in sporadic carcinoma, but bears a striking resemblance to that seen during neoplastic progression in Barrett's oesophagus. These results support a causal role for chronic inflammation in cancer development in CUC, and treatment of ulcerative colitis should aim to minimise inflammation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16049281      PMCID: PMC1770877          DOI: 10.1136/jcp.2004.017418

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  16 in total

1.  Significance and detection of dysplasia in chronic colitis.

Authors:  H Goldman
Journal:  Cancer       Date:  1996-12-01       Impact factor: 6.860

2.  Mesalazine inhibits activation of transcription factor NF-kappaB in inflamed mucosa of patients with ulcerative colitis.

Authors:  H Bantel; C Berg; M Vieth; M Stolte; W Kruis; K Schulze-Osthoff
Journal:  Am J Gastroenterol       Date:  2000-12       Impact factor: 10.864

3.  Distinction between dysplasia-associated lesion or mass (DALM) and adenoma in patients with ulcerative colitis.

Authors:  F Fogt; S J Urbanski; M E Sanders; E E Furth; R L Zimmerman; J J Deren; A E Noffsinger; A O Vortmeyer; C J Hartmann; R L Odze; C A Brown
Journal:  Hum Pathol       Date:  2000-03       Impact factor: 3.466

4.  Comparison of genetic alterations in colonic adenoma and ulcerative colitis-associated dysplasia and carcinoma.

Authors:  F Fogt; A O Vortmeyer; H Goldman; T J Giordano; M J Merino; Z Zhuang
Journal:  Hum Pathol       Date:  1998-02       Impact factor: 3.466

Review 5.  Nitric oxide in gastrointestinal epithelial cell carcinogenesis: linking inflammation to oncogenesis.

Authors:  M Jaiswal; N F LaRusso; G J Gores
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2001-09       Impact factor: 4.052

6.  Neoplastic progression in ulcerative colitis: histology, DNA content, and loss of a p53 allele.

Authors:  G C Burmer; P S Rabinovitch; R C Haggitt; D A Crispin; T A Brentnall; V R Kolli; A C Stevens; C E Rubin
Journal:  Gastroenterology       Date:  1992-11       Impact factor: 22.682

Review 7.  Chronic inflammation, apoptosis and (pre-)malignant lesions in the gastro-intestinal tract.

Authors:  C J van der Woude; J H Kleibeuker; P L M Jansen; H Moshage
Journal:  Apoptosis       Date:  2004-03       Impact factor: 4.677

8.  Colon carcinogenesis in inflammatory bowel disease.

Authors:  S H Itzkowitz; B Greenwald; S J Meltzer
Journal:  Inflamm Bowel Dis       Date:  1995       Impact factor: 5.325

9.  Clinical and pathomorphological findings in patients with colorectal carcinoma complicating ulcerative colitis.

Authors:  A Schneider; M Stolte
Journal:  Z Gastroenterol       Date:  1993-03       Impact factor: 2.000

10.  Expression of apoptosis-related proteins in Barrett's metaplasia-dysplasia-carcinoma sequence: a switch to a more resistant phenotype.

Authors:  C J van der Woude; P L M Jansen; A T G M Tiebosch; A Beuving; M Homan; J H Kleibeuker; H Moshage
Journal:  Hum Pathol       Date:  2002-07       Impact factor: 3.466

View more
  7 in total

1.  Alpha-lipoic acid attenuates trinitrobenzene sulfonic acid-induced ulcerative colitis in mice.

Authors:  Jing Sun; Huijing Zhang; Lin Guan; Huan Zhou; Mingjun Sun
Journal:  Int J Clin Exp Med       Date:  2015-01-15

Review 2.  Inflammatory colonic carcinogenesis: a review on pathogenesis and immunosurveillance mechanisms in ulcerative colitis.

Authors:  Marco Scarpa; Ignazio Castagliuolo; Carlo Castoro; Anna Pozza; Melania Scarpa; Andromachi Kotsafti; Imerio Angriman
Journal:  World J Gastroenterol       Date:  2014-06-14       Impact factor: 5.742

3.  Upregulation of RICTOR gene transcription by the proinflammatory cytokines through NF-κB pathway contributes to the metastasis of renal cell carcinoma.

Authors:  Bo Sun; Liwei Chen; Hui Fu; Lin Guo; Hua Guo; Ning Zhang
Journal:  Tumour Biol       Date:  2015-10-25

4.  β-2 microglobulin is unsuitable as an internal reference gene for the analysis of gene expression in human colorectal cancer.

Authors:  Yasuhiro Nihon-Yanagi; Kensuke Terai; Takeyoshi Murano; Takayuki Kawai; Shinya Kimura; Shinichi Okazumi
Journal:  Biomed Rep       Date:  2013-01-10

5.  Human and mouse colon cancer utilizes CD95 signaling for local growth and metastatic spread to liver.

Authors:  Hanchen Li; Xueli Fan; Calin Stoicov; Jian Hua Liu; Sharif Zubair; Elena Tsai; Ronald Ste Marie; Timothy C Wang; Stephen Lyle; Evelyn Kurt-Jones; Jeanmarie Houghton
Journal:  Gastroenterology       Date:  2009-06-12       Impact factor: 22.682

6.  Deoxycholate-induced colitis is markedly attenuated in Nos2 knockout mice in association with modulation of gene expression profiles.

Authors:  Harris Bernstein; Hana Holubec; Carol Bernstein; Natalia A Ignatenko; Eugene Gerner; Katerina Dvorak; David Besselsen; Karen Ann Blohm-Mangone; Jose Padilla-Torres; Barbora Dvorakova; Harinder Garewal; Claire M Payne
Journal:  Dig Dis Sci       Date:  2007-03       Impact factor: 3.487

Review 7.  Biomarkers for colitis-associated colorectal cancer.

Authors:  Ru Chen; Lisa A Lai; Teresa A Brentnall; Sheng Pan
Journal:  World J Gastroenterol       Date:  2016-09-21       Impact factor: 5.742

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.